Abstracts

New SIVsmm Strains to Achieve Control of Virus Replication With Conventional ART in Rhesus Macaques

Background: There is a renewed enthusiasm for a “cure research” aimed at understanding the mechanisms of HIV-1 persistence and developing therapeutic strategies to reduce and ultimately eliminate viral reservoirs. Limitations of human clinical studies make it imperative to develop analogous and tractable animal models for cure research. However, a major limitation of animal use is…

Viral Suppression was Induced by Anti-PD-L1 Following ARV-Interruption in SIV-Infected Monkeys

Background: BMS-936559, a fully human antibody against huPD-L1, was tested in antiretroviral-suppressed SIVmac251-infected rhesus macaques. The primary endpoints for this study were to assess safety during repeated i.v. administration of BMS-936559, to determine any improvement in the function of SIV-specific T cells and to monitor for effects on viral recrudescence after cessation of ARV therapy.…

Systems Biology HIV Disease and RNAs Big and Small

Background: Systems biology, encompassing high-throughput molecular profiling technologies and computational methods, provides the means for comprehensive interrogation of the host response to infection. My laboratory is using systems biology to understand and model integrated views of virus-host interactions, to computationally screen for antiviral drugs, and to identify correlates of immunity in nonhuman primate evaluations of…

Identification of Novel B*57:01 Restricted Peptides From HIV gp140 Using Immunopeptidomics

Background: A small fraction of HIV-infected patients known as “elite controllers” maintain very low levels of plasma HIV and near normal levels of CD4+T-cells without antiretroviral therapy. The majority of these long-term non-progressors possess HLA alleles such as HLA-B*57:01 or -B*27:05 that are thought to offer superior T-cell mediated immunity. The majority of peptide epitopes…

CoRSeqV3: Novel Coreceptor Usage Prediction Algorithms for HIV-1 Subtypes B, C, D and CRF01_AE

Background: Maraviroc (MVC) is a CCR5 antagonist used in HIV-1 antiretroviral therapy that can only be prescribed to patients with exclusively CCR5- using virus populations. Thus reliable determination of HIV-1 coreceptor usage in patients is clinically important for prescription of MVC. Genotypic coreceptor usage prediction algorithms, based on HIV-1 V3 sequence, have been developed as…

Divergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic SIV infections

Background: Pathogenic SIV infection of rhesus macaques (RM) results in infection and progressive depletion of central memory CD4+ T cells (TCM) which predicts the overall loss of CD4+ T cell homeostasis. In contrast, nonpathogenic SIV infection of sooty mangabeys (SM) is characterized by limited infection and preservation of CD4+ TCM. Recent studies have identified a…

Dynamics of B Cell Subpopulations in*Pathogenic and Nonpathogenic SIV infections

Background: We compared and contrasted the dynamics of B cells subpopulations in mononuclear cells from blood, lymph nodes (LN) and intestine (INT) in progressive SIV infection of pigtailed macaques (PTMs) and in non-progressive SIV infection of African green monkeys (AGMs) to elucidate the significance of B-cell changes observed in HIV/SIV infection. Methodology: We assessed the…

CD39/CD73/Adenosine Pathway in Progressive vs Non-progressive infections

Background: The CD39/CD73/adenosine (ADO) pathway was associated with immunosuppression in multiple diseases; yet, its precise role in mediating immune activation and inflammation (IA/INFL) during HIV-1/SIV infection remains unclear. Methodology: We compared and contrasted the expression of markers related to either ADO production (CD39 and CD73) or ADO breakdown (CD26) on both regulatory (Tregs) and conventional…